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between 1 January 2003 and 31 July 2008 [1]. At 3-year fol-
low-up, mortality and the incidence of both ischaemic and 
bleeding events were strongly related to age. With a 3-year 
mortality of ± 40 %, reinfarction in ± 23 %, bleeding in 1/3 
of patients and stroke in 1/12 of patients ≥ 80 years, it is 
clear that there is a large potential for improvement and it is 
certainly appropriate to give this problem a more prominent 
place on our scientific agenda. However, before embarking 
on the collection and description of more registry data, or 
even, as the authors suggest, a dedicated randomised con-
trolled trial, we should consider some issues to place these 
findings in perspective.
Patient selection
To be included in this cohort, the elderly STEMI patient 
had to reach the cathlab and they had to survive the primary 
angioplasty procedure. In a paper entitled ‘Changing trends 
in, and characteristics associated with, NOT undergoing 
cardiac catheterisation in elderly adults hospitalised with 
ST-segment elevation acute myocardial infarction’, Tis-
minetzky et al. describe the decade long (1999–2009) trends 
in the rate of NOT undergoing angiography and angioplasty 
and the factors associated with not undergoing these pro-
cedures in an observational population-based study in the 
setting of Worchester, Massachusetts [2]. Older adults who 
develop STEMI are increasingly likely to undergo cardiac 
catheterisation and angioplasty, but several high-risk groups 
often still do not make it to the cathlab, including women, 
individuals with prior infarction and those with various 
comorbidities. From a population perspective outcomes are 
likely to be considerably worse compared with the patients 
described by the AMC investigators.
The elderly are the fastest growing part of the population in 
Western countries and aged individuals constitute a rapidly 
increasing proportion of patients presenting with acute cor-
onary syndromes (ACS), including ST-elevation myocar-
dial infarction (STEMI). Advanced age is a strong predictor 
of adverse outcome. Unfortunately, most reported ACS tri-
als have included limited numbers of patients over 75 or 80 
years of age, and therefore limited data are available on the 
best management of this growing subset of the ACS popu-
lation. Recommended therapies are sometimes withheld 
in very old individuals, due to lack of proof of benefit for 
this age group and the high risk of serious side effects and 
complications. This is, at least in part, also due to specific 
clinical characteristics of these patients at initial presenta-
tion. Symptoms following acute coronary occlusion are less 
specific, electrocardiographic patterns more often not the 
typical pattern of ST-segment elevation and confounding 
morbidity may all contribute to diagnostic uncertainty and 
delayed or ‘conservative’ decision-making.
In this issue of the Netherlands Heart Journal, Claessen et 
al. attempt to fill in the gaps in our knowledge, by a detailed 
description of a cohort of 196 patients aged ≥ 80 years as 
part of the 2002 patients treated with primary angioplasty 
for STEMI at the Academic Medical Center Amsterdam 
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If patients make it to the cathlab, are we doing better?
In a report from the Swedish coronary angiography and 
angioplasty registry (SCAAR), Velders et al. describe 4876 
elderly STEMI patients [3]. Procedural success and prog-
noses of these patients > 80 years remained similar during 
a 10-year period, despite changes in patient characteristics 
and treatment. The good news of this report is that although 
advanced age strongly increased the risk of adverse events, 
survivors of the early phase had a slightly improved progno-
sis compared with the general population. However, this can 
also be interpreted as further evidence for patient selection 
bias and undertreatment.
Bleeding complications
Access site related as well as non-access related bleeding 
has a negative impact on quality of life and is related to 
short- and long-term prognosis. In particular, gastrointesti-
nal bleeding is related to a number of risk factors includ-
ing age and the use of triple antithrombotic therapy (oral 
anticoagulation + dual antiplatelet therapy) and is a strong 
independent predictor of all-cause mortality at 1 year [4].
Implications
The authors conclude that ‘especially in this high-risk 
patient group individualised therapy is needed to optimise 
clinical outcomes’. We will attempt to be more specific.
 ● Presentation: We should be aware that acute coronary 
occlusion in elderly patients often results in ‘atypical’ 
clinical presentations, in particular in women, and that 
the sensitivity and specificity of the electrocardiographic 
changes in these patients are modest, resulting in a risk 
of underdiagnosis.
 ● Decision-making: Although ischaemic time is important 
in some STEMI patients, in the elderly the impact of a 30 
or even 60 minute delay is very modest or even absent 
[5]. See also for instance Tables 3 and 4 of the Supple-
mentary Appendix of the Claessen paper. All elderly 
patients with suspected ACS should therefore undergo 
a thorough clinical evaluation prior to a decision to pro-
ceed or not to proceed to the cathlab.
 ● Pharmacotherapy: As heparin is difficult to dose, in 
particular in the elderly, measure ACT or APTT, avoid 
overdosing and be aware that many patients receive 
heparin in the ambulance. If at all possible do not use 
glycoprotein IIb/IIIa inhibitors. In view of the relatively 
high incidence of atrial fibrillation in the elderly, do not 
discharge patients with oral anticoagulation + dual anti-
platelet therapy, but with oral anticoagulation + clopido-
grel [6]
 ● In the cathlab: go radial and keep it simple: stent the 
ruptured plaque, not the entire infarct-related artery. As 
long as you do not know the renal function, restrict con-
trast use. The incidence of acute heart failure and respi-
ratory failure in these patients is considerable, be certain 
that somebody pays attention to the patient while you are 
focused on optimising the angiographic result of the pri-
mary angioplasty. As the majority of these patients have 
multivessel disease, consider staged procedures with 
fractional flow reserve guidance as the preferred option 
for revascularisation of non-infarct related arteries.
The AMC investigators deserve a compliment for the col-
lection of detailed clinical data in combination with 3-year 
follow-up of a large contemporary cohort of elderly primary 
angioplasty patients. The topic certainly deserves more 
attention and on the basis of these data a collaborative effort 
(under auspices of ICIN?) to address the important remain-
ing issues seems urgently needed.
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